Cite Filings / PCRX / 0001140361-26-044522
Feed Companies Filings Check
Sign in
S-8 POS

Post-effective Amendment

Pacira BioSciences, Inc. · Filed 2026-11-17 · Acc 0001140361-26-044522

Documents 1

  • S-8 POS Post-effective Amendment , ef20085675_s8pos.htm

Around this filing

  • 2026-11-17 4 Chief Executive Officer returned 660,830.84 shares (to the company)
  • 2026-11-17 25-NSE Notification of Removal from Listing
  • 2026-11-17 S-8 POS Post-effective Amendment
  • 2026-11-17 S-8 POS Post-effective Amendment
  • 2026-11-17 8-K Material agreement · Agreement ended · Acquisition or sale completed · Debt accelerated · Delisting notice · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
  • 2026-11-17 SC 14D9/A SC 14D9/A
  • 2026-11-17 SC TO-T/A Tender Offer Statement

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading ef20085675_s8pos.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…